protarget / Home -

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://protarget.dk/sitemap_index.xml # --------------------------- # END YOAST

Meta Tags

Title	Home -
Description	A Danish Nationwide Clinical Trial on TargetedCancer Treatment Based on Genomic
Keywords	N/A

Server Information

WebSite	protarget.dk
Host IP	93.191.156.42
Location	Denmark

Related Websites

                        Site
                        Rank
                    

More to Explore

protarget.dk Valuation

US$1,592

Last updated: 2023-05-19 21:49:57

protarget.dk has Semrush global rank of 0. protarget.dk has an estimated worth of US$ 1,592, based on its estimated Ads revenue. protarget.dk receives approximately 183 unique visitors each day. Its web server is located in Denmark, with IP address 93.191.156.42. According to SiteAdvisor, protarget.dk is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,592
Daily Ads Revenue	US$1
Monthly Ads Revenue	US$44
Yearly Ads Revenue	US$529
Daily Unique Visitors	12
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
protarget.dk.	A	3600	IP: 93.191.156.42
protarget.dk.	NS	3600	NS Record: ns4.simply.com.
protarget.dk.	NS	3600	NS Record: ns3.simply.com.
protarget.dk.	NS	3600	NS Record: ns2.simply.com.
protarget.dk.	NS	3600	NS Record: ns1.simply.com.
protarget.dk.	MX	3600	MX Record: 10 mx.simply.com.
protarget.dk.	TXT	3600	TXT Record: v=spf1 include:spf.simply.com -all

HtmlToTextCheckTime:2023-05-19 21:49:57

About Research Partners Contact ProTarget A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling Latest News News from the ProTarget trial 22 Mar Selpercatinib is included as a new drug in ProTarget We are pleased to announce that Retsevmo (selpercatinib) is now available in ProTarget. Patients with a confirmed variant-drug match to selpercatinib may be eligible to inclusion in this study arm. Selpercatinib is a RET inhibitor belonging to the class of can... Read More 28 Feb ProTarget is happy to be an active partner in PCM4EU, which is a EU4H (EU for Health) project consortium recently launched Cancer is one of the leading causes of death and morbidity in the EU with 3,7M new cases each year. Personalised Cancer Medicine (PCM) is an emerging approach with the potential to beat this disease. However, the success of PCM depends on access to adequate mo... Read More About us The ProTarget study - A Danish Nationwide Clinical Trial on Targeted Cancer

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 03 Dec 2022 02:32:06 GMT
Server: Apache
Content-Security-Policy: upgrade-insecure-requests;
Location: https://protarget.dk/
Content-Type: text/html; charset=iso-8859-1

HTTP/2 200 
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
content-security-policy: upgrade-insecure-requests;
x-content-type-options: nosniff
simplycom-server: Apache
content-type: text/html; charset=UTF-8
date: Sat, 03 Dec 2022 02:32:06 GMT
server: Apache

protarget.dk valuation and analysis